Update on headache.
The late 1990s have witnessed an unprecedented growth in understanding of the pathophysiology of headache and treatment options. This article will briefly review the current pathophysiology and classification scheme, and will focus on abortive and preventative options in the treatment of headache.
Sharfman
M
M
Treatment Institute, Winter Park, Florida, USA.
D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D004878:Ergotamine / Q000627:therapeutic use; D006261:Headache / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D018579:Patient Selection; D018170:Sumatriptan / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D018712:Analgesics, Non-Narcotic; D014662:Vasoconstrictor Agents; D018170:Sumatriptan; D004878:Ergotamine